Authors:
Wymer, N
Buchanan, LV
Henderson, D
Mehta, N
Botting, CH
Pocivavsek, L
Fierke, CA
Toone, EJ
Naismith, JH
Citation: N. Wymer et al., Directed evolution of a new catalytic site in 2-keto-3-deoxy-6-phosphogluconate aldolase from Escherichia coli, STRUCTURE, 9(1), 2001, pp. 1-9
Citation: Cf. Dailey et al., Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus, ANTIM AG CH, 45(8), 2001, pp. 2304-2308
Authors:
Hester, JB
Gibson, JK
Buchanan, LV
Cimini, MG
Clark, MA
Emmert, DE
Glavanovich, MA
Imbordino, RJ
LeMay, RJ
McMillan, MW
Perricone, SC
Squires, DM
Walters, RR
Citation: Jb. Hester et al., Progress toward the development of a safe and effective agent for treatingreentrant cardiac arrhythmias: Synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potential, J MED CHEM, 44(7), 2001, pp. 1099-1115
Authors:
McMahon, SA
Leonard, GA
Buchanan, LV
Giraud, MF
Naismith, JH
Citation: Sa. Mcmahon et al., Initiating a crystallographic study of UDP-galactopyranose mutase from Escherichia coli (vol 55, pg 399, 1999), ACT CRYST D, 55, 1999, pp. 1108-1108
Authors:
McMahon, SA
Leonard, GA
Buchanan, LV
Giraud, MF
Naismith, JH
Citation: Sa. Mcmahon et al., Initiating a crystallographic study of UDP-galactopyranose mutase from Escherichia coli, ACT CRYST D, 55, 1999, pp. 399-402
Authors:
Buchanan, LV
Mehta, N
Pocivavsek, L
Niranjanakumari, S
Toone, EJ
Naismith, JH
Citation: Lv. Buchanan et al., Initiating a structural study of 2-keto-3-deoxy-6-phosphogluconate aldolase from Escherichia coli, ACT CRYST D, 55, 1999, pp. 1946-1948